EB 33, an epithelial cell line from human prostate carcinoma: a review.
The cell line EB 33 was cultivated from the tissue of a human prostate adenocarcinoma in June 1973. Since that time, efforts have been made by scientists in several laboratories to characterize this line by morphologic, biochemical, endocrinologic, genetic, and immunologic parameters. The great need for a well-defined prostatic cell line for immunologic experimentation warrants a complete review of the subject.
D000135:Acid Phosphatase / Q000378:metabolism; D000818:Animals; D002460:Cell Line; D002869:Chromosome Aberrations; D013196:Dihydrotestosterone / Q000494:pharmacology; D004848:Epithelium / Q000473:pathology; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D006801:Humans; D007109:Immunity; D008297:Male; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000473:pathology; D009376:Neoplasms, Hormone-Dependent / Q000473:pathology; D011471:Prostatic Neoplasms / Q000201:enzymology / Q000209:etiology / Q000473:pathology; D014183:Transplantation, Heterologous
D013196:Dihydrotestosterone; D005954:Glucosephosphate Dehydrogenase; D000135:Acid Phosphatase